-
TENX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Tenax Therapeutics (TENX)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 98.31 mm | 98.31 mm | 98.31 mm | 98.31 mm | 98.31 mm | 98.31 mm |
Cash burn (monthly) | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) | 1.02 mm |
Cash used (since last report) | n/a | n/a | n/a | n/a | n/a | 2.84 mm |
Cash remaining | n/a | n/a | n/a | n/a | n/a | 95.47 mm |
Runway (months of cash) | n/a | n/a | n/a | n/a | n/a | 93.8 |
13F holders | Current |
---|---|
Total holders | 7 |
Opened positions | 2 |
Closed positions | 5 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 15.22 mm |
Total shares | 579.90 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Intracoastal Capital | 479.73 k | $840.00 k |
Stuart Rich | 95.48 k | $142.00 k |
Qube Research & Technologies | 4.41 k | $13.40 mm |
MS Morgan Stanley | 260.00 | $784.00 k |
BAC Bank of America | 16.00 | $48.00 k |
RY Royal Bank of Canada | 1.00 | $0.00 |
Allworth Financial | 1.00 | $4.00 k |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Dec 24 | June Sherie Almenoff | Stock Option Common Stock | Grant | Acquire A | No | No | 5.94 | 100,000 | 594.00 k | 100,000 |
10 Dec 24 | Michael H. Davidson | Stock Option Common Stock | Grant | Acquire A | No | No | 5.94 | 100,000 | 594.00 k | 100,000 |
10 Dec 24 | Doogan Declan | Stock Option Common Stock | Grant | Acquire A | No | No | 5.94 | 100,000 | 594.00 k | 100,000 |
10 Dec 24 | Chrisopher Thomas Giordano | Stock Option Common Stock | Grant | Acquire A | No | No | 5.94 | 1,250,000 | 7.43 mm | 1,250,000 |
10 Dec 24 | Robyn Hunter | Stock Option Common Stock | Grant | Acquire A | No | No | 5.94 | 100,000 | 594.00 k | 100,000 |